Lupin today announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States. Loteprednol Etabonate Ophthalmic Suspension, 0.5% is bioequivalent to Lotemax Ophthalmic ...

Lupin introduces loteprednol etabonate ophthalmic suspension, 0.5% in US: Our Bureau, Mumbai Wednesday, July 16, 2025, 16:20 Hrs [IST] Global pharma major Lupin Limited (Lupin) an ...

Lupin announced that it has launched Loteprednol Etabonate Ophthalmic Suspension in the United States.

Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5%, a generic equivalent to Lotemax, for eye inflammation treatment.

Mumbai: Global pharma major Lupin Limited has launched Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United ...